About: Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 18 November 2009

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 2010 (uk) im Februar 2010 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 18 November 2009 (en) artículu científicu espublizáu en payares de 2009 (ast)
publication date	wds:Q58947783-D0F33955-3D18-4A79-A338-F99B70995541
publication date	2009-11-18 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58947783-F8C95EA2-370E-4148-83FE-D6368001250E
language of work or name	English
exact match	wds:Q58947783-B5750F64-A95F-47A7-B346-5ADC5FA6412A
exact match	https://scigraph.springernature.com/pub.10.1038/ki.2009.419
cites work	wds:Q58947783-0D512379-D5F7-4797-8357-BA42D2588912 wds:Q58947783-11EADF90-36CD-42B2-AF4A-E4BD2A19AADB wds:Q58947783-1B6D5AA5-4CC9-4C8E-A152-686BE0E3B3C8 wds:Q58947783-20B13A78-7746-4277-AF10-C4EFD3388C07 wds:Q58947783-23F59CE2-DD70-4335-B531-4BD0B488A143 wds:Q58947783-2B1397B8-0A61-47C4-82FD-941729AFB8B3 wds:Q58947783-356DC67B-C951-4902-99F4-CAE9407203C1 wds:Q58947783-3ACE0927-8422-49B4-B08E-7003E062E7F2 wds:Q58947783-50FE5F99-87C9-4926-B3F4-027B9DA0A45E wds:Q58947783-58799E44-5B5B-46FF-BC23-1799786146AE wds:Q58947783-58DE2ADC-C589-435A-A6CB-C33BDFE3A440 wds:Q58947783-5A35020D-99E9-4808-8177-789207BCBED7 wds:Q58947783-5C9F14DA-1689-47F9-B544-0EEC3C118DDB wds:Q58947783-635BAE85-BD09-4EDA-B99E-EFE3E89B76A5 wds:Q58947783-691BBE9A-E1F3-4887-970B-7B576B0BB42C wds:Q58947783-7BAF77E2-D82A-4AF0-BF76-E5BA8596A2BD wds:Q58947783-80E40737-2655-4BC8-A089-F342B232AAD8 wds:Q58947783-85989500-BA34-4DC7-A87B-5844B7D3E3DF wds:Q58947783-8EDDA3CC-9BBD-49AC-A7D1-E19FCB4BCFCE wds:Q58947783-9512BF40-20F7-4B11-9B43-C93F5569E276 wds:Q58947783-9F28B1E0-FF61-4AF4-B4BF-23023CA36B54 wds:Q58947783-A0A69A6D-5FF3-48B8-8C14-5A21FDD3283F wds:Q58947783-A5744151-B5E7-47C9-AE8E-FFE7020AA038 wds:Q58947783-A5DDD8CB-23F3-4E6A-B035-98D3DE6D0BD6 wds:Q58947783-A70A2803-9A17-4126-A714-83C7BF6C1D08 wds:Q58947783-ACAF7128-EAE4-44D8-A68F-E93227563D7D wds:Q58947783-C7EF268E-9074-41B9-94CB-45FE3618F07F wds:Q58947783-CE4145A4-4899-48F4-B472-FA62C5B817A6 wds:Q58947783-D8FC5C72-D818-481D-89A8-33E5A91484C1 wds:Q58947783-DB3FEBD1-C456-4C41-8002-8D49A4C83B24 wds:Q58947783-DD03DE25-52A1-43C8-AC5E-28F597B2586F wds:Q58947783-E16587ED-5482-4F5D-9E71-E9D89523D314 wds:Q58947783-E300986D-4AFA-4119-AFB4-492D6E989D34 wds:Q58947783-E4F35BD8-195C-469A-A750-04FA28791ED4 wds:Q58947783-EABBB3D3-63F6-4604-B0DB-66E9B356E341
cites work	Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14 Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE) Advanced glycation end products: sparking the development of diabetic vascular injury Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts Tissue-specific expression patterns of the RAGE receptor and its soluble forms—a result of regulated alternative splicing? RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control Cardiovascular risk in uraemic patients-is it fully explained by classical risk factors? Advanced glycation and lipoxidation end products: reactive carbonyl compounds-related uraemic toxicity Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Soluble receptor for advanced glycation end products in patients with decreased renal function. Are advanced glycation end products cardiovascular risk factors in patients with CRF? Advanced glycation end products in renal failure Serum levels of total homocysteine, homocysteine metabolites and of advanced glycation end-products (AGEs) in patients after renal transplantation. Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals Advanced glycation end products and mortality in hemodialysis patients Interaction between nutrition and inflammation in hemodialysis patients Pregnancy-Associated Plasma Protein A and Soluble Receptor for Advanced Glycation End Products after Kidney Transplantation The concept of ventricular/vascular coupling: functional and structural alterations of the heart and arterial vessels go in parallel
author name string	wds:Q58947783-0509860F-C175-4259-AC68-40E5205E15C4 wds:Q58947783-1645B726-8DD5-458A-BCC2-14B5FA40157F wds:Q58947783-171ECE29-A57D-40FA-9F88-8FA67A3D6718 wds:Q58947783-73FB0876-EBB9-40A9-B53D-C39482DC9A56 wds:Q58947783-A0FBFE10-85BD-4D5A-B7F9-6D73259BF71B wds:Q58947783-E4128EAB-B9CB-4C35-989B-BC2C78393F06 wds:Q58947783-EEB41585-2984-4D49-87EC-38D1AE2F32D4
author name string	Francesca Mallamaci Giovanni Tripepi Rocco Tripepi Daniela Leonardis Sebastiano Cutrupi Patrizia Pizzini Lorena Gaetano
rdfs:label	Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease (en) Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease (nl)
skos:prefLabel	Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease (en) Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease (nl)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software